IW27. Are There Limits to Boundary Limits?Chairperson: Malkah
T. Notman, M.D.
IW28. Children of Psychiatrists: Listen and LearnCo-Chairpersons: Leah J. Dickstein, M.D., Michelle B. Riba, M.D.
IW29. ABPN and APA Perspectives on Maintenance of CertificationChairperson: Stephen C. Scheiber, M.D.
IW30. How to Launch a Successful Private Practice (Part 1)Co-Chairpersons: William E. Callahan Jr., M.D., Keith W. Young,
IW31. Pain Management of the Chemically Dependent PatientChairperson: Jeffrey A. Berman, M.D.
IW32. Strategies for Success for Early Career Academic Psychiatrists
(Part 1): Writing for PublicationChairperson: Laura W. Roberts, M.D.;
Collaborative Session With the National Institute of Mental Health
IW33. Decisional Capacity in the Consultation-Liaison Setting:
Controversies and DifficultiesChairperson: Ramaswamy Viswanathan,
IW34. Psychiatric Hospice on an ACT Team: When Mental Illness Is
TerminalCo-Chairpersons: Curtis N. Adams Jr., M.D.. Ann L. Hackman,
IW35. Detection of Malingering in Disability EvaluationsChairperson: Roger Z. Samuel, M.D.
IW36. Teaching Psychosomatic Medicine for Primary Care Physicians: What,
How, and Where?Chairperson: Hoyle Leigh, M.D.
IW37. Shakespeare, Psychiatry, and PsychopathologyChairperson:
Steven E. Pflanz, M.D.
IW38. Uncovering Medical Causes of Functional Decline in the
Developmentally DisabledChairperson: Stephen M. Soltys, M.D.
IW39. Drug Companies in Training Clinics: Economic Necessity Versus
Undue InfluenceCo-Chairpersons: Edward A. Volkman, M.D., Ruth M.
IW40. Driving Miss DaisyCo-Chairpersons: Theron C. Bowers Jr.,
M.D., Sheila M. Loboprabhu, M.D.
IW41. Psychiatrists Intervening Upstream: Good Practices for Preventing
Violence in Children, Youth, and FamiliesChairperson: Guiseppe
Raviola, M.D.; Collaborative Session With the National Institute of Mental
IW42. Cultural Competence in the Clinical Encounter: Irma Bland and
Evelyn LeeChairperson: Francis G. Lu, M.D.
IW43. A New Model for the Treatment of Relational DisordersCo-Chairpersons: Glenn N. Siegel, M.D., Mary Pittman, M.S.
Research Advances in Medicine
Exploring New Frontiers and Clinical ApplicationsChairperson:
Charles B. Nemeroff, M.D.; Co-Chairperson: Marian I. Butterfield,
Continuous Clinical Case Conference 1.Eva M. Szigethy, M.D.,
John Campo, M.D., David DeMaso, M.D., Eyal Shemesh, M.D., on Control What
You Can: Successful Treatment of Teenagers in Chronic Pain (Part 2) (for
APA members only)
13. Joel Yager, M.D., on Career Building in Academic and
Nonacademic Psychiatry (for residents only)
14. Tana A. Grady-Weliky, M.D., on Effective Teaching: What
Psychiatry Residents Need to Know
15. John A. Chiles, M.D., on Assessment and Treatment of Suicidal
Patients (Meet the Authors)
L12. Psychiatry in the Genomic EraThomas R. Insel, M.D., APA's
Judd Marmor Award Lecture; Collaborative Session With the National Institute
of Mental Health
L13. To Be AnnouncedAPA's Patient Advocacy Award
Master Educator Clinical Consultations
7. Josepha A. Cheong, M.D., on Geriatric Psychiatry (for APA
8. Silvia W. Olarte, M.D.(for APA members only)
Medical Update 2.Sara Berga, M.D., on Stress-Induced
Anovulation: Mind Over Matter
Research Consultation 2.Helen S. Mayberg, M.D., on
Functional Neuroimaging Strategies in Affective Disorders Research
Collaborative Session With the National Institute of Mental
Scientific and Clinical Report Sessions
Session 10. Epidemiology and Other Issues in Psychiatry
29. Parental Separation at Birth and Schizophrenia and Depression Pirjo
H. Maki, M.D.
30. Parental Separation at Birth and Substance-Use Disorder Juha M.
31. Pica Syndrome: Review and Relevance Jambur V. Ananth, M.D.
Session 11. Somatic Therapies
32. The Impact of Electroconvulsive Therapy on Quality of Life and Function
W. Vaughn McCall, M.S.
33. Seizures Targeted to Circuitry: New Forms of Convulsive Therapy
Sarah H. Lisanby, M.D.; Collaborative Session With the National Institute
of Mental Health
34. Ethical and Legal Implications of Psychiatric Evaluation of Pediatric
Gastric Bypass Gagan Dhaliwal, M.D.
Session 12. Cognitive Disorders
35. Is Depression a Risk Factor for Cognitive Impairment? A Meta-Analysis
of 20 Cohort Studies Alex J Mitchell, M.D.
36. Treatment of Agitation and Psychosis in Elderly Patients With Dementia
Pierre N. Tariot, M.D.
37. Prevalence of Dementia in a Southern-European Population in Two
Different Time Periods Pedro Saz, M.D.
Session 13. Psychosomatic Medicine
38. Somatization Increases Medical Care Utilization and Costs Arthur J.
39. The Integrated Management of Medically Unexplained Symptoms Donald
40. Medical and Psychiatric Comorbidities of a Substance-Abusing
Public-Assistance Population Bruce J. Schwartz, M.D.
Session 14. Biological Psychiatry and Neuroscience
41. Brainstem Control of Neurotic and Psychotic Processes Jacques St.
42. Brain Stimulation: Why, Where, and How? Harold A. Sackeim, Ph.D.;
Collaborative Session With the National Institute of Mental Health
43. New Findings on Daily Prefrontal Repetitive Transcranial Magnetic
Stimulation for Depression Mark S. George, M.D.; Collaborative Session
With the National Institute of Mental Health
Session 15. Aspects of Bipolar Disorder
44. Negative Impact of Medical Comorbidity on the Course of Bipolar
Disorder Dan V. Iosifescu, M.D.; Collaborative Session With the National
Institute of Mental Health
45. Lithium Continuation/Discontinuation After Four Years of Stability
Eric D. Peselow, M.D.
46. Magnitude of the Effects of Quetiapine Treatment in Bipolar Disorder
Wayne Macfadden, M.D.
Session 16. Child and Adolescent Psychopharmacology
47. Pediatric Formulation of Modafinil Effective in Children and
Adolescents With ADHD James M. Swanson, M.D.
48. Modafinil Pediatric Formulation Has Early and Sustained Effect in ADHD
Joseph Biederman, M.D.
49. Polypharmacy Among Youths: How Prevalent Is It? Farifteh F.
Session 17. PTSD and Anxiety
50. PTSD Depression and Anger in Patients Recovered From SARS Rima
51. Are Anxiety Disorders Underdiagnosed and Undertreated in Psychiatry?
Joshua E. Wilk, Ph.D.
52. Biological Findings in PTSD: Can They Be Changed by Psychotherapy?
Friedhelm Lamprecht, M.D.
Session 18. Issues in Biological Psychiatry
53. The Family Genetic Study of Pathological Gambling Donald W. Black,
54. Metabolic Syndrome in Psychiatric Inpatients Receiving Antipsychotics
John W. Goethe, M.D.
55. Anorexia Nervosa and Bulimia Nervosa: From Culture to Genes Pamela
K. Keel, Ph.D.; Collaborative Session With the National Institute of Mental
S27. Neuroscience for the Psychiatrist (Part 1): Neuroimaging From
Genomics to TherapyCollaborative Session With the National Institute
of Mental Health
A. Imaging Genomics in Psychiatry Andreas Meyer-Lindenberg,
B. fMRI: Basics and Beyond Peter A. Bandettini, Ph.D.
C. Understanding Schizophrenia Using Functional Brain Imaging Cameron
D. Linking Imaging and Treatment Mechanisms for Depression Helen S.
S28. Real-Life Medical Management of HIV
A. HIV Treatment Update Khakasa H. Wapenyi, M.D.
B. Managing Mood Disorders Milton L. Wainberg, M.D.
C. Managing Hepatitis C, Syphilis, and HIV Infection Annette M.
D. Managing Psychosis Shahrad R. Amiri, M.D.
E. Managing Metabolic Syndromes Marshall Forstein, M.D.
S29. Psychosomatic Medicine: Integrating Epidemiology, Psychiatry, and
A. Risk of Myocardial Infarction Associated With Panic Disorder Andres
B. The Prevalence of Depressive Disorders in Patients With Dementia in
IHCIS Dimitri Bennett, M.D.
C. Diabetes and Lipid-Profile Risks With Neuroleptics: Two- to Five-Year
Outcome Robert C. Joseph, M.D.
D. Somatic Complaints in Traumatized Children Ruby C. Castilla-Puentes,
E. A Case-Control Study of Erectile Dysfunction Among Men Diagnosed With
Panic Disorder William Blumentals, Ph.D.
S30. The Art and Science of Brief Therapies
A. Expectancy, the Ignored Common Factor: Creating Hope in Psychotherapy
Roger P. Greenberg, Ph.D.
B. Solution-Focused Brief Therapy: Doing What Works Brett Steenbarger,
C. Brief Interpersonal Therapy Scott Stuart, M.D.
D. Cognitive Therapy: Practice and Training Judith S. Beck,
S31. Posttraumatic Stress and Medical Illness: Interdisciplinary
A. PTSD in Medically Ill Adults and Children: A Review Eyal Shemesh,
B. PTSD Symptoms in Children Who Had Transplants: One Center's Experience
Sukru Emre, M.D.
C. The Study of PTSD in the Medically Ill: Choice of Outcome Measures
Gad Cotter, M.D.
D. The National Child Traumatic Network Medical Trauma Toolkit Margaret
L. Stuber, M.D.
S32. Medical Comorbidity in the U.S. and France: Vive La Difference!French Federation of Psychiatry
A. Mortality in a Cohort of Patients With Schizophrenia Frederic
B. Prevalence, Treatment, and Prevention of HIV/Hepatitis in the U.S.
Lisa B. Dixon, M.D.
C. Adverse Metabolic Effects of Antipsychotics in Schizophrenia Marie
France Poirier, M.D.
D. Diabetes and Other Metabolic Disorders in Schizophrenia Michael J.
E. The Impact of Smoking in Patients With Schizophrenia Alain Dervaux,
F. Medical Comorbidities and Health Behaviors: Smoking, Exercise, and
Weight Gail L. Daumit, M.D.
S33. Medical and Psychiatric Issues in the Mexican-American Population
in the U.S.
A. Health Status of Mexican Americans Michael P. Stern, M.D.
B. Depression as Comorbid Condition With Type-2 Diabetes in a U.S.-Mexico
Border Community Clinic Roberto Villarreal, M.D.
C. Insights on Schizophrenia in Three Countries Rolando A. Medina,
S34. Atypical Antipsychotics: Treatment of Agitation Across Mental
A. Treatment of Agitation With Atypical Antipsychotics in Schizophrenia
Stephen R. Marder, M.D.
B. Treatment of Agitation With Atypical Antipsychotics in Bipolar Affective
Disorder Gary S. Sachs, M.D.
C. Treatment of Agitation With Atypical Antipsychotics in Alzheimer's
Disease Jacobo E. Mintzer, M.D.
D. Assessing the Data in the Context of Clinical Care Eric D. Caine,
S35. The Many Faces of Depression: Do Antidepressants Treat Different
A. Do Antidepressants Treat Different Core Symptoms of Depression? J.
Craig Nelson, M.D.
B. Anger Attacks in Depression: Does 5HT Matter? Maurizio Fava,
C. Positive and Negative Affect and Antidepressant Response Pedro L.
D. How Do Antidepressants Affect the Processing of Posistive and Negative
Emotional Information? Catherine J. Harmer, D.Phil.
E. The Role of Dopamine in Depression: Implications for Treatment
Anthony J. Rothschild, M.D.
S36. Understanding and Treating Alcohol Dependence
A. Neuropharmacological Basis of Alcohol Dependence George F. Koob,
B. New Pharmacological Strategies for Treating Alcohol Dependence
Barbara J. Mason, Ph.D.
C. Recent Developments in the Genetics of Alcohol Dependence Marc A.
D. New Medications: The Use of Anticonvulsants, Both Alone and in
Combination With Various Forms of Psychotherapy Bankole A. Johnson,
E. Differential Effects of Pharmacological Agents on Craving Nassima
S37. Evidence-Based Psychiatry: What It Is and What It Is Not
A. Evidence-Based Medicine in Psychiatry: An Overview Gregory E. Gray,
B. Evidence-Based Approaches to Teaching and Practicing Psychopharmacology
David N. Osser, M.D.
C. Uses and Abuses of EBM in Psychiatry S. Nassir Ghaemi, M.D.
D. Evidence-Based Medicine: How It Can Be Misused David T. Healy,
E. EBM and Pharmaceutical Industry-Sponsored Clinical Trials Amir H.
S38. How to Launch a Successful Private Practice (Part 3)
A. Personal Factors Leading to a Successful Private Practice William E.
Callahan Jr., M.D.
B. Office Location and Design for Efficiency and Success Keith W.
C. Streamlining Overhead and Managing Your Business in Private Practice
Keith W. Young, M.D. D. Marketing Your Unique Private Practice
William E. Callahan Jr., M.D.
S39. Complex Pharmacotherapy Versus Polypharmacy
A. Polypharmacy and Ethnic Minorities William Lawson, M.D.
B. Impulsive Behavior in Children and Adolescents Janice G. Hutchinson,
C. Polypharmacy in Depression and Anxiety: What, When, and How to Implement
Gabriela Cora-Locatelli, M.D.
D. Complexities of Bipolar Illness Typically Require Complex Combination
Therapy Robert M. Post, M.D.
E. Polypharmacy in Schizophrenia Treatment David C. Henderson,
S40. Integrating and Sequencing Treatments for Borderline
A. Phases and Stages of Change in the Treatment of Personality Disorder
John Livesley, Ph.D.
B. Adapting Dialectical Behavior Therapy for the Psychiatric Practitioner
Barbara H. Stanley, Ph.D.
C. Common Mechanisms in Psychological Theories: Attachment and
Mentalization Peter Fonagy, Ph.D.
D. Toward a Rational Pharmacotherapy of BPD Larry J. Siever,
E. Psychoeducation for Family Members With a Relative With BPD Perry D.
S41. Maternal Depression and Comorbidities: Impact on Infants
A. Maternal Depression and Comorbidities: PTSD and BPD Marian I.
B. Perinatal Depression: Impact of Maternal Distress on Neonatal Outcomes
and Attachment Sheila M. Marcus, M.D.
C. Impact of Maternal BPD on Infant Emotional Regulation Gisèle
D. How Early Life Experience Affects the Development of Optimism's Neural
Circuitry Susan C. Vaughan, M.D.
S42. ADHD: From Neuroscience to PracticeCollaborative Session
With the National Institute of Mental Health
A. Psychiatric and Functional Outcome of Adolescent Females With ADHD: A
Large, Controlled, Five-Year Longitudinal Follow-Up Study Joseph
B. Nonstimulant Treatment of Adult ADHD Thomas J. Spencer,
C. Neuropsychology of ADHD: Clinical and Scientific Implications of Recent
Findings Alysa E. Doyle, Ph.D.
D. Heritability: New Genetic Findings in ADHD Pamela Sklar,
E. Looking at the ADHD Brain: Neuroimaging Studies in ADHD Larry J.
S43. Associations Between Stress/Anxiety and Personality Styles and
DisordersAssociation for Research in Personality Disorders
A. A Selective Overview of Relationship of Anxiety and Personality
Disorders James H. Reich, M.D.
B. Schema Therapy for Maladaptive Personality Traits Involving Anxiety
C. Personality and Stress in Three Phases of the Physician's Career: A
Longitudinal Nationwide Study Per Vaglum, M.D.
D. Panic, Rage, and Family Discord in BPD David M. Allen, M.D.
E. Is Emotional Dyscontrol and Impulsivity Related to Suicidal Ideation in
BPD Patients? Navjot Chaudhary, B.S.C.
F. Stress, Personality Disorders, and Opioid Receptors Kenneth Silk,
S44. Perinatal Depression: Prevalence, Screening Accuracy, and
A. A Systematic Review of the Evidence on the Incidence and Prevalence of
Perinatal Depression Norma I. Gavin, Ph.D.
B. What Is the Accuracy of Different Screening Tools for Detecting
Depression During the Perinatal Period? Bradley N. Gaynes, M.D.
C. Does Perinatal Screening for Depressive Symptoms With Subsequent
Intervention Lead to Improved Outcomes? A Systematic Review of the Evidence
Samantha E. Meltzer-Brody, M.D.
S45. The Long-Term Psychological Aftermath of 9/11-Related Traumatic
A. Traumatic Grief Among 9/11 Victims Yuval Y. Neria, Ph.D.
B. Trauma, Bereavement, and Traumatic Loss George A. Bonanno,
C. A Nationwide Longitudinal Study of Responses to the 9/11 Terrorist
Attacks Roxane C. Silver, Ph.D.
D. Loss and Consequences After Mass Trauma: Examples From the 9/11
Terrorist Attacks in New York City Sandro Galea, M.D.
E. 9/11-Related Traumatic Loss and Its Psychopathology in Primary Care
Patients in New York City Raz Gross, M.D.
S46. Rehabilitation of the Mad or Bad: GloballyAmerican
Association for Psychosocial Rehabilitation and the World Psychiatric
Association's Section on Rehabilitation
A. Mad or Bad? Japan Naotaka Shinfuku, M.D.
B. Mad or Bad? United States Zebulon Taintor, M.D.
C. Mad or Bad? Hungary Ida Kosza, M.D.
D. Mad or Bad? Pakistan Afzal Javed, M.D.
E. Mad or Bad? International Efforts Humberto Martinez, M.D.
S47. New Developments in the Treatment of Somatoform Disorders
A. Pharmacotherapy of Somatoform Disorders Brian A. Fallon,
B. Managing Common Somatic Presentations in Primary Care: Cultural
Considerations Javier I. Escobar, M.D.
C. Cognitive-Behavior Therapy for Hypochondriasis: A Randomized, Controlled
Intervention Trial Arthur J. Barsky, M.D.
D. Treatment of Unexplained Somatic Symptoms in Children and Adolescents
Joshua D. Lipsitz, Ph.D.
E. Integrative Treatment for Fibromyalgia/Chronic Fatigue Syndrome
Richard P. Brown, M.D.
S48. Inpatient Psychiatry: Crisis and Response
A. Public Policy and Inpatient Psychiatric Care Anita S. Everett,
B. An Updated Model for Inpatient Psychiatric Care Ira D. Glick,
C. Crisis Residential Care for Patients With Serious Mental Illness:
Outcomes and Cost Wayne S. Fenton, M.D.
D. A National Referral Center for Treatment-Resistant Patients Edward
R. Shapiro, M.D.
E. Trends and Characteristics of Inpatient Treatment in Routine Psychiatric
Practice in the U.S. Joshua E. Wilk, Ph.D.
S49. Advances and Innovations in Assessing Decision-Making
A. Evaluating Decisional Capacity in Older Patients Barton W. Palmer,
B. Error Behaviors in Capacity Interviews Scott Y. Kim, M.D.
C. Distinguishing Research From Clinical Care Laura B. Dunn,
D. Capacity for Informed Consent in Patients With Schizophrenia David
J. Moser, Ph.D.
S50. Novel Research Treatments for Eating DisordersCollaborative Session With the National Institute of Mental
A. Atypical Antipsychotic Medication for Anorexia Nervosa Evelyn Attia,
B. New Medication Treatments for Binge-Eating Disorder Jose C.
C. CD-ROM-Based Treatment for Binge-Eating Disorder and Obesity Cynthia
M. Bulik, Ph.D.
D. How the Study of Mechanism May Inform Treatment of Bulimia Nervosa
B. Timothy Walsh, M.D.
E. D-Cycloserine and Anorexia Nervosa: Clinical Implications of
Translational Research Joanna E. Steinglass, M.D.
S51. Neuroscience and Dynamic PsychiatryAmerican Academy of
Psychoanalysis and Dynamic Psychiatry
A. Psychotherapy and Neurobiology Richard M. Brockman, M.D.
B. Contemporary Affect Theory and Controversies Regarding Drive Theory in
Psychoanalysis Otto F. Kernberg, M.D.
C. Imaging the Mind-Brain Interface Bridging the
Psychoanalysis-Neuroscience Gap David A. Silbersweig, M.D.
D. How Neuroscience Can Help the Clinician Samuel Slipp, M.D.
S52. Disturbed Fronto-Limbic Brain Circuitry: How Specific Is It for
Different Psychiatric Disorders?
A. Fronto-Limbic Brain Pathology: Evidence From Animal Research Gregory
B. Fronto-Limbic Brain Pathology in PTSD Eric Vermetten, M.D.
C. Prefrontal and Limbic Pathology in BPD Klaus Lieb, M.D.
D. Stress-Induced Brain Structural Plasticity: What Do Animal Models Tell
Us? Bruce S. McEwen, Ph.D.
E. Neural Circuits in Trauma Spectrum Disorders J. Douglas Bremner,
S53. Increases in Opioid Analgesic Abuse: Concerns and StrategiesNational Institute on Drug Abuse
A. Increases in Opioid Analgesic Use, Misuse, and Addiction Wilson M.
Compton III, M.D.
B. The Availability of Opioid Medications Over the Internet Without a
Prescription Robert F. Forman, Ph.D.
C. Managing Chronic Pain in the Patient With Comorbid Substance Abuse
Nathaniel P. Katz, M.D.
D. Treatment of Prescription Analgesic Abuse Herbert D. Kleber,
S54. Psychiatry and the Pharmaceutical Industry: Where Is the
A. Pharmaceutical Promotions: Effects on the Practice of Psychiatry Amy
C. Brodkey, M.D.
B. Academic Medicine, Medical Education, and the Pharmaceutical Industry
Frederick S. Sierles, M.D.
C. The Pharmaceutical Industry, Psychiatry, and the Public Interest
Robert M. Factor, M.D.
D. Dancing With Porcupines: Dilemmas Faced by Speakers for the
Pharmaceutical Industry Diana M. Koziupa, M.D.
S55. Autism: A Common, Severe, Treatable, and Neglected Psychiatric
IllnessCollaborative Session With the National Institute of Mental
A. A Comprehensive Review of Major Research Findings in Autism From the
Past Decade Eric B. London, M.D.
B. Biology of Social Behavior From Mice to Monkeys James T. Winslow,
C. fMRI Studies of Social Perception and Social Cognition in Autistic
Disorder Robert T. Schultz, Ph.D.
D. Targeted Treatments for the Repetitive Behavior Domain in Autism
Eric Hollander, M.D.
E. Atypical Antipsychotics in Children With Pervasive Developmental
Disorders Lawrence Scahill, Ph.D.
Review of Psychiatry (Section 1): Sleep Disorders and PsychiatryChairperson: Daniel J. Buysse, M.D.
1. Insomnia Daniel J. Buysse, M.D.
2. Sleep-Related Breathing Disorders Patrick J. Strollo, M.D.
3. Restless Leg Syndrome and Parasomnias John W. Winkelman,
4. Circadian Rhythm Sleep Disorders Phyllis C. Zee, M.D.
New Research Poster Session 7
Global Disasters: Psychiatric Medicine and Public Health ChallengesAPA Council on Global Psychiatry and World Psychiatric Association
Conflict Management and Conflict Resolution Section, Co-Chairpersons: Rodrigo
A. Muñoz, M.D., Eliot Sorel, M.D.; Presenters: Srinivan Murthy, M.D.,
M. Paramsheva Deva, M.D., Lennart Levi, M.D.; Discussants: Professor Mordechai
Benyakar, Anthony T. Ng, M.D.
IS39. Seasonal Affective Disorder: New Concepts, Practical
StrategiesSupported by GlaxoSmithKline
A. The Clinical Picture and Epidemiology of SAD Norman E. Rosenthal,
B. Pathophysiology of Seasonal Affective Disorder Thomas A. Wehr,
C. Light Treatment for Winter Depression: Status Report Raymond W. Lam,
D. Medical Treatment Including Mechanism of Action: New Study Data
Jennifer K. Pennell, M.D.
E. Integrating Cognitive-Behavioral Therapy Into Seasonal Affective
Disorder Treatment Kelly J. Rohan, Ph.D.
IS40. Alcoholism: Translating Emerging Science Into Clinical
PracticeSupported by Alkermes
A. Animal Models Point the Way to Novel Therapies George F. Koob,
B. Brain Imaging of Craving and the Effects of Anticraving Medications
Charles P. O'Brien, M.D.
C. Advances in the Pharmacotherapy of Alcoholism Helen M. Pettinati,
D. Alcoholism and Other Psychiatric Disorders: How Do We Manage Dual
Diagnosis? Hugh Myrick, M.D.
IS41. Advances in Cholinergic Therapy: Alzheimer's Disease and
BeyondSupported by Eisai Inc.
A. Revisiting the Cholinergic Hypothesis: Are Cholinesterase Inhibitors
More Than Symptomatic Treatments for Alzheimer's Disease? Norman Relkin,
B. The Role of Imaging in the Study and Treatment of Dementia K. Ranga
R. Krishnan, M.D.
C. Clinical Trials in Cognitive Impairment Ronald C. Petersen,
D. Pharmacological Treatment of Cognitive Impairments in Schizophrenia
Robert W. Buchanan, M.D.
E. Behavioral Disturbances in Alzheimer's Disease: Diagnosis and Management
Helen Lavretsky, M.D.
IS42. Challenges at the Interface of Psychiatric, Medical, and Sleep
DisordersSupported by Sanofi-Synthelabo Inc.
A. Epidemiological and Longitude Perspectives on Insomnia and Psychiatric
Illness Daniel E. Ford, M.D.
B. Changing Women's Sleep Vulnerabilities Across the Life Cycle Lois
C. Sleep Disturbances and Neurodegenerative Disorders Raymond R. Auger,
D. Metabolic Consequences of Insomnia: Implications for Medicine and
Psychiatry Gary S. Richardson, M.D.
E. Therapeutic Challenges in Treating Insomnia With Comorbid Psychiatric
and Medical Disorders David N. Neubauer, M.D.
IS43. It's Not Just for Kids: ADHD in Adolescence and AdulthoodSupported by Shire US Inc.
A. The Course of ADHD From Adolescence Into Adulthood Christopher J.
B. Neurobiological Update on ADHD in Adolescence and Adulthood Stephen
V. Faraone, Ph.D.
C. New Psychotherapies Directed at Young Adults With ADHD Steven A.
D. College Considerations in Young Adults With ADHD Sharon B. Wigal,
E. Medication Considerations in Young Adults With ADHD Timothy Wilens,